Urinalysis to exclude and monitor nephrotoxicity

Clinica Chimica Acta

Volumn 297, Issue 1-2, 2000, Pages 173-182

  Price, Robert G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Battery of tests; Biomarkers; Early markers; Nephrotoxicity; Sequence of kidney damage; Urine analysis

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; HEAVY METAL; LEAD; MERCURY; SOLVENT;

ADULT; ARTICLE; CONTROLLED STUDY; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; PATIENT MONITORING; POLLUTION; PRIORITY JOURNAL; URINALYSIS; WORKER;

EID: 0034076686     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00244-8     Document Type: Article

References (24)

1. Principles and methods for the assessment of nephrotoxicity associated with the exposure to chemicals. WHO Environ Health Criteria. 119:1991;1-266.
2. Biomarkers in urinary toxicology. 1995;16-185 National Academy Press, Washington, DC.
3. Mueller P.W., Lash L., Price R.G., et al. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. I. Categories of tests for detecting effects of nephrotoxins. Renal Failure. 19:(4):1997;505-521.
4. Taylor S.A., Chivers I.D., Price R.G., et al. The assessment of the utility of biomarkers to detect nephrotoxicity using an integrated database. Environ Res. 75:1997;23-33.
5. Finn W.F., Porter G.A. Urinary biomarkers: recommendations of the joint European/United States workshop for future research. Renal Failure. 21:1999;445-451.
6. Price R.G., Patel S., Chivers I., Milligan P., Taylor S.A. Early markers of nephrotoxicity: Detection of children at risk from environmental pollutants. Renal Failure. 21:1999;303-308.
7. Guder W.G., Ivandic M., Hofman W. Physiopathology of proteinuria and laboratory diagnostic strategy based on single protein analysis. Clin Chem Lab Med. 36:1998;935-939.
8. Wedeen R.P., Udasin I., Fielder N., et al. Urinary biomarkers as indicators of renal disease. Renal Failure. 21:1999;241-249.
9. Fels L.M., Herbort C., Pergrande M. Nephron target sites in chronic exposure to lead. Nephrol Dial Transplant. 9:1994;1740-1746.
10. Price R G. Urinary enzymes, nephrotoxicity and renal disease. Toxicology. 23:1982;99-134.
11. Mutti A., Alvinovi E., Bergamaschi E., et al. Nephropathies and exposure to organic solvents: a survey of dry-cleaners exposed to perchloroethylene. Lancet. 340:1992;189-193.
12. Cardenas A., Roels H., Barbon R., et al. Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med. 50:1993;17-27.
13. Cardenas A., Roels H., Barbon R., et al. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med. 50:1993;28-36.
14. Roels H., Bernard A M., Cardenas A., et al. Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med. 50:1993;37-48.
15. Price R.G., Taylor S.A., Chivers I., et al. Development and validation of new screening tests for nephrotoxic effects. Hum Exp Toxicol. 15:1996;S10-19.
16. Roels H.A., Hoet P., Lison D. Usefulness of biomarkers of exposure to inorganic mercury, lead or cadmium in controlling occupational and environmental risks of nephrotoxicity. Renal Failure. 21:1999;251-262.
17. Price R.G., Berndt W.O., Finn W.F., et al. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. III. Minimal battery of tests to assess subclinical nephrotoxicity for epidemiological studies based on current knowledge. Renal Failure. 19:(4):1997;535-552.
18. Burke T., Hauchman F.S., Anderson H., et al. Role of exposure databases in risk management. Arch Environ Health. 47:1992;421-429.
19. Mueller P.W., Price R.G., Finn W.F. New approaches to detecting human nephrotoxicity using cadmium as an example. Environ Health Perspect. 106:1998;227-230.
20. Fels L.M., Wunsch M., Baranowski J., et al. Adverse effects of chronic low level lead exposure on kidney function - a risk group study in children. Nephrol Dial Transplant. 13:1998;2248-2256.
21. Hofman W., Ivandic M., Guder W.G. Marker der tubulären nierenfunktion und ihr einbau in eine diagnostische strategie. J Lab Med. 23:1999;339-345.
22. Viberti G.C., Marshall S., Beech R., et al. Report on renal disease in diabetes. Diabetic Med. 13:1996;S6-S12.
23. Watts G.F., Vlitos M.A.J., Morris R.W., Price R.G. Urinary N-acetyl-β-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control. Diabetes Metab. 14:1988;653-658.
24. UK prospective study. X. Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridemia. Diabetologia. 36:1993;1021-1029.